Achiko AG Logo

Achiko AG

ACHI | SW

Overview

Corporate Details

ISIN(s):
CH0522213468
LEI:
Country:
Switzerland
Address:
Tessinerplatz 7, 8002 Zürich
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Achiko AG was a health technology company that developed aptamer-based diagnostic solutions and companion mobile health applications. Its primary products included AptameX™, a biotechnology division for diagnostics, and Teman Sehat, a digital health passport app. The company focused on creating an ecosystem for COVID-19 management by integrating a rapid, low-cost test with its mobile software. As of July 2023, the company is in liquidation and has been delisted from the Swiss Stock Exchange.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Achiko AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-12-21 06:45
Regulatory News Service
Achiko AG Production and Sales Update
English 13.2 KB
2022-12-21 01:00
Earnings Release
Achiko AG Production and Sales Update
English 11.1 KB
2022-12-21 01:00
Earnings Release
Achiko AG Produktions- und Vertriebsupdate
German 18.3 KB
2022-12-20 18:00
Post-Annual General Meeting Information
2022 Ordinary Shareholders Meeting of Achiko AG: Shareholders adopt all proposa…
English 9.6 KB
2022-12-20 01:00
Post-Annual General Meeting Information
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all propos…
English 8.0 KB
2022-12-20 01:00
Post-Annual General Meeting Information
Ordentliche Generalversammlung 2022 der Achiko AG: Aktionäre nehmen alle Anträg…
German 8.5 KB
2022-11-25 18:10
Pre-Annual General Meeting Information
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 15.9 KB
2022-11-25 01:00
Pre-Annual General Meeting Information
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 14.4 KB
2022-11-25 01:00
Pre-Annual General Meeting Information
Die Achiko AG lädt ihre Aktionäre zur ordentlichen Hauptversammlung am 20. Deze…
German 14.4 KB
2022-11-17 16:10
Investor Presentation
Achiko AG Announces Corporate Update Webcast
English 16.9 KB
2022-11-17 01:00
Regulatory News Service
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-17 01:00
Regulatory News Service
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 15.0 KB
2022-11-16 16:20
Report Publication Announcement
Achiko AG Announces Corporate Update Webcast
English 17.0 KB
2022-11-16 01:00
Regulatory News Service
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-16 01:00
Report Publication Announcement
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 14.9 KB

Automate Your Workflow. Get a real-time feed of all Achiko AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Achiko AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Spago Nanomedical AB Logo
Develops nanomedicine for precision MRI tumor diagnostics and targeted cancer radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Developing first-in-class macrocyclic drugs for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops and out-licenses preclinical cancer drug programs using fragment-based discovery.
Sweden SPRINT
Stayble Therapeutics AB Logo
Develops an injectable therapy for disc-related spinal disorders as an alternative to surgery.
Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo
Commercializes patented MIC-1 stem cell technology for regenerative medicine.
Poland SCS
STRIX GROUP PLC Logo Isle of Man KETL
SynAct Pharma Logo
Developing oral resolution therapies for inflammatory diseases like rheumatoid arthritis.
Sweden SYNACT
SYNAIRGEN PLC Logo
Develops an inhaled interferon beta therapy for severe viral lung infections.
United Kingdom SNG
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT
Israel TMIS